Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
NSA2 pseudogene 3 is a non-coding genomic element resembling the functional NSA2 gene, itself responsible for nucleolar processes and ribosome assembly[1]. As a pseudogene, NSA2P3 may participate in gene regulatory networks at the RNA level, acting as a decoy for microRNAs or generating RNA species capable of modulating the expression of related genes[2][3][5]. There is currently no evidence that NSA2P3 produces protein or serves as a therapeutic target. Most pseudogenes, including NSA2P3, are not directly targeted by drugs but may be relevant to disease via their roles in RNA-based regulatory processes. Important clarification: NSA2P3 is NOT considered a therapeutic target, receptor, enzyme, transporter, or similar druggable entity. It is a pseudogene—genomically similar to NSA2 but lacking clear functional protein-coding capacity or direct pharmacological relevance[1][2][3][4][5].
None established for drugs (pseudogenes are not direct drug targets)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on NSA2 pseudogene 3 (NSA2P3).